Stock VNDA VANDA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Real-time Estimate Cboe BZX
Other stock markets
 11:00:04 2024-05-17 am EDT 		5-day change 1st Jan Change
5.625 USD +0.81% Intraday chart for Vanda Pharmaceuticals Inc. +11.71% +33.41%
May. 15 Vanda Pharmaceuticals Says Second Phase 3 Study of Tradipitant in Motion Sickness Yields 'Positive' Results MT
May. 15 Vanda Pharmaceuticals Inc. Reports Positive Results from A Second Phase III Study of Tradipitant in Motion Sickness CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vanda Pharmaceuticals Adopts Stockholder Rights Plan; Shares Rise
MT
Vanda Pharmaceuticals' Board Rejects all Unsolicited Takeover Proposals From Future Pak
MT
Oil ticks up as markets weigh U.S. debt deal, rate hike possibility
RE
Jefferies Downgrades Vanda Pharmaceuticals to Hold From Buy, Adjusts Price Target to $12 From $24
MT
Wall Street Sees Lower Open as Jobs Report Stirs Interest Rate Fears
MT
VANDA PHARMACEUTICALS : BofA Securities Starts Vanda Pharmaceuticals at Buy With $22 Price Target
MT
VANDA PHARMACEUTICALS : Citigroup Downgrades Vanda Pharmaceuticals to Neutral From Buy; Price Target is $14
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VNDA Stock
  4. News Vanda Pharmaceuticals Inc.
  5. Analyst Reco.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW